2024 annual financial data
Elicio Therapeutics 2024 Operating margin
Elicio Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -44,986,000 USD and net income was -51,898,000 USD.
Operating cash flow was -37,068,000 USD.
Get free Elicio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -44,986,000 USD
- Net income
- -51,898,000 USD
- Operating cash flow
- -37,068,000 USD